View Clinical Trial (Medical Research Study)
Three Methods of Ureteral Stent Measurement: Which Method Improves Quality of Life After Ureteral Stenting?
| City: |
|
Charleston |
| State: |
|
West Virginia |
| Zip Code: |
|
25301 |
| Conditions: |
|
Quality of Life |
| Purpose: |
|
To examine a patient's quality of life using three methods for measuring stent size: (a)
direct measurement, (b) patient height, and (c) a standardized formula. The intent of the
study is to show if there is a difference in a patient's quality of life, postoperative
symptoms, pain medication and anticholinergic use by using one of these specific methods for
stent size determination. No method is interventional in this study.
|
| Study Summary: |
|
Ureteral stent placement is common in Urologic practice and many studies have been done
looking at factors to improve stent related symptoms, but few have used a validated
questionnaire to assess these symptoms affect on quality of life.We plan to prospectively
randomize patients to three separate techniques such as (a) direct measurement,(b) patient
height, and (c) a standardized formula for the determination of stent size. Using a
validated questionnaire, the Ureteral Stent Symptoms Questionnaire (USSQ), we will assess
whether there is a difference in outcome measures such as patient quality of life, need for
pain medications and anticholinergics, and in postoperative symptoms based on one of these
techniques. The USSQ was developed by Joshi et al to assess the impact of health-related
quality of life issues related to ureteral stents. Data from USSQ questionnaire will be
collected 7-10 days post-operatively as well as 4 weeks post-op and then this will be
aggregated for our outcome measures to determine which method of stent size give better
outcomes.
|
| Criteria: |
|
Inclusion Criteria:
- All patients presenting to Charleston Area Medical Center between the ages of 18 and
90 years old who will undergo cytoscopy or ureteroscopy with ureteral stent placement
will be eligible for the study.
Exclusion Criteria:
- Patients excluded from this study will be those who are less than 18 years of age,
pregnant women, and patients who are septic on presentation, as well as patients who
have had lower extremity amputations or are wheelchair bound.
|
| NCT ID: |
|
NCT00919386 |
| Primary Contact: |
|
Principal Investigator
Julio G. Davalos, M.D.
CAMC Medical Staff - with admitting privileges
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Charleston, West Virginia 25301
United States
Samuel Deem, D.O.
Phone: 304-388-8250
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 23, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|